Quick Answer
CorMedix Inc. reported Cash And Cash Equivalents At Carrying Value of $144.84 million for the year ending 2025.
- CorMedix Inc. showed an increase of +256.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2006 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $144.84 million | Fiscal year 2024: $40.65 million | Fiscal year 2023: $43.64 million | Fiscal year 2022: $43.15 million | Fiscal year 2021: $53.32 million | Fiscal year 2020: $41.91 million | Fiscal year 2019: $16.35 million | Fiscal year 2018: $17.62 million | Fiscal year 2017: $10.38 million | Fiscal year 2016: $8.06 million | Fiscal year 2015: $11.82 million | Fiscal year 2014: $4.34 million | Fiscal year 2013: $2.37 million | Fiscal year 2012: $835.5 thousand | Fiscal year 2011: $1.99 million | Fiscal year 2010: $8.28 million | Fiscal year 2009: $1.51 million | Fiscal year 2006: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: